bioRxivBiophysicsPreprint
ASPL-driven subunit exchange remodels VCP/p97 hexamers and is impaired by a multisystem proteinopathy mutation
Jingxuan Tang, Laxmikanta KhamariiD, Benjamin J. T. Dodd, Guoming GaoiD, Liuhan DaiiD, Stephanie L. MooniD, Nils G. WalteriD
Abstract
Valosin-containing protein (VCP/p97) is an essential homohexameric AAA+ ATPase that powers ubiquitin-dependent protein quality control by extraction and unfolding of clients for proteasomal degradation. Heterozygous, autosomal-dominant VCP missense mutants are associated with multisystem proteinopathy (MSP) through unclear molecular mechanisms. We developed a single-molecule pull-down assay to quantify VCP hexamer assembly and subunit exchange dynamics directly in human cell lysate. We show the common MSP-associated VCP variant R155H co-assembles with wild-type subunits to form heterohexamers. Wild-type VCP complexes readily undergo subunit exchange in cell lysates, but this exchange is markedly reduced for purified complexes in buffer. We identify the VCP-interactor ASPL as a selective mediator of monomer exchange that efficiently remodels wild-type, but only modestly exchanges R155H variants within multimers. Single-molecule kinetics analyses reveal [~]2-fold faster ASPL association with, and [~]4-fold slower dissociation from, wild-type VCP than R155H-VCP. We propose that ASPL-driven monomer exchange remodels VCP molecular machines to sustain proteostasis. The failure of ASPL-driven exchange of MSP variant monomers would be predicted to stabilize mutant VCP in assemblies, revealing a potentially targetable defect.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fatty links between multisystem proteinopathy and Small VCP-Interacting Protein
F. Ramzan, F. Abrar, … D. D. O. Martin·bioRxiv·Mar 31, 2023
- A Novel Autosomal Dominant Childhood-Onset Disorder Associated with Pathogenic Variants in VCP
Annelise Yoo Mah-Som, Jil Daw, … Marwan S. Shinawi·medRxiv·Jun 19, 2023
- Distinct modes of coupling between VCP, an essential unfoldase, and deubiquitinases
Lauren E. Vostal, Noa E. Dahan, … Tarun M. Kapoor·The Journal of Cell BiologyPeer-reviewed·Feb 10, 2025
- Novel VCP activator reverses multisystem proteinopathy nuclear proteostasis defects and enhances TDP-43 aggregate clearance
Jessica M. Phan, Benjamin C. Creekmore, … Edward B. Lee·bioRxiv·Mar 15, 2023
- Antisense oligonucleotides targeting Valosin-containing protein improve muscle pathology and molecular defects in cell and mouse models of multisystem proteinopathy.
Pallabi Pal, Michele Carrer, … Virginia E. Kimonis·bioRxiv·Jul 25, 2025
- In silico Study of the Uncertainly Significant VCP Variants reveal major Structural, Functional fluctuations leading to potential Disease-Based Associations
Tathagata Das, Saileyee Roychowdhury, Parimal Das·bioRxiv·Nov 4, 2023